UNMATCHED REAL-WORLD DATA

Convincing and substantial evidence for the Medtronic Symplicity Spyral™ Renal Denervation (RDN) system

DOWNLOAD THE JACC MANUSCRIPT
Play Video This will play a video - Dr. Markus Schlaich

Prof. Markus Schlaich discusses Global Symplicity Registry data on renal denervation in patients with resistant hypertension.

RDN INSIGHTS  FROM TCT CONNECT 2020

Watch interviews with experts on the latest data in renal denervation from TCT Connect 2020.

Play Video This will play a video - Dr. Andrew Sharp

Prof. Andrew Sharp reviews data on the durability of renal denervation from animal histology and insights into human renal anatomy.

RDN IS PROVEN TO REDUCE BLOOD PRESSURE

The Medtronic RDN system is proven to reduce blood pressure.1 Specifically, the Symplicity Spyral™
multi-electrode RDN catheter lowered blood pressure
in the SPYRAL HTN-OFF MED Pivotal clinical trial.

EXPLORE PIVOTAL DATA
Bar chart showing blood pressure change from the SPYRAL OFF MED Pivotal Trial office SBP.

CLINICAL EVIDENCE COVERS MORE THAN 12,000 PATIENT-YEARS OF FOLLOW-UP2

VIEW CLINICAL SUMMARIES

WELL TESTED. WELL PROVEN.

The SPYRAL HTN Global Clinical Trial program is a multi-phase, global study program.

SEE THE RESULTS

LONG-TERM DATA ABOUT SAFETY AND EFFICACY

The GSR confirms safety and efficacy in the real world through three years in a variety of patients representative of daily clinical practice.3

REVIEW THE FINDINGS

ADDITIONAL DATA

There are many physician-initiated studies on RDN that provide further detail and understanding of the procedure.

BROWSE STUDIES
Female physician who performs the renal denervation (RDN) procedure for hypertensive patients.

WANT TO LEARN MORE ABOUT RDN?

Receive new RDN data as it becomes available.

SIGN UP FOR EMAIL
*

ANCOVA Adjusted

1

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 2020; Published online March 29, 2020. DOI: 10.1016/S0140-6736(20)30554-7

2

Medtronic Data on File.

All rights reserved. Medtronic, Medtronic logo are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.